Allogene Therapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP ALLO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

91,253

Value ($000)

125

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	125	0.0%	91,253	12/31/2025
2025 Q3	11/14/2025	85	0.0%	68,500	9/30/2025
2025 Q2	8/14/2025	344	0.0%	304,812	6/30/2025
2025 Q1	5/14/2025	230	0.0%	157,644	3/31/2025
2024 Q4	2/14/2025	327	0.0%	153,602	12/31/2024
2024 Q3	11/14/2024	231	0.0%	82,456	9/30/2024
2024 Q2	8/15/2024	204	0.0%	87,742	6/30/2024
2024 Q1	5/7/2024	428	0.0%	95,806	3/31/2024
2023 Q4	2/14/2024	800	0.0%	249,311	12/31/2023
2023 Q3	11/14/2023	1,035	0.0%	326,366	9/30/2023
2023 Q2	8/11/2023	1,680	0.0%	337,976	6/30/2023
2023 Q1	5/16/2023	2,470	0.0%	499,934	3/31/2023
2022 Q4	2/14/2023	409	0.0%	64,980	12/31/2022
2022 Q3	11/14/2022	2,195	0.0%	203,219	9/30/2022
2022 Q2	8/15/2022	1,846	0.0%	161,912	6/30/2022
2022 Q1	5/16/2022	1,631	0.0%	179,020	3/31/2022
2021 Q4	2/14/2022	3,645	0.0%	244,329	12/31/2021
2021 Q3	11/15/2021	2,611	0.0%	101,623	9/30/2021
2021 Q2	8/11/2021	2,233	0.0%	85,626	6/30/2021
2021 Q1	5/17/2021	5,445	0.0%	154,250	3/31/2021
2020 Q4	2/16/2021	1,561	0.0%	61,840	12/31/2020
2020 Q3	11/16/2020	809	0.0%	21,452	9/30/2020
2020 Q2	8/14/2020	1,037	0.0%	24,213	6/30/2020
2020 Q1	5/15/2020	932	0.0%	47,923	3/31/2020